We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Blast Drugmakers for High Prices, Look to Biosimilars
Lawmakers Blast Drugmakers for High Prices, Look to Biosimilars
August 5, 2008
Lawmakers outraged by what they call extraordinary drug price increases have asked the Government Accountability Office to see if the increases are justified and directed the Federal Trade Commission (FTC) to investigate a drug firm’s potential anti-competitive conduct for one product.